FDA Panel , Endorses
COVID Vaccines, for Children Under 5.
On June 15, an advisory panel to the United States
Food and Drug Administration voted to recommend
two COVID-19 vaccines for kids ages 5 and under.
Yahoo reports that both Pfizer/BioNTech
and Moderna were under review by the panel. .
The unanimous FDA panel vote
is the first step in what is predicted
to be a quick authorization process.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
Yahoo reports that parents now
have two options for how
to vaccinate their children.
Pfizer's vaccine for kids is delivered in three,
three-microgram doses, while Moderna's vaccine
is delivered in two shots of a 25-microgram dose.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
The committee’s support today
is imperative to providing a critical tool
for pediatricians, parents, and caregivers
who eagerly await an option
for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo.
Both companies are now awaiting approval from
the FDA and the CDC which will hold an advisory
committee meeting on the topic over the weekend.
COVID Vaccines, for Children Under 5.
On June 15, an advisory panel to the United States
Food and Drug Administration voted to recommend
two COVID-19 vaccines for kids ages 5 and under.
Yahoo reports that both Pfizer/BioNTech
and Moderna were under review by the panel. .
The unanimous FDA panel vote
is the first step in what is predicted
to be a quick authorization process.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
Yahoo reports that parents now
have two options for how
to vaccinate their children.
Pfizer's vaccine for kids is delivered in three,
three-microgram doses, while Moderna's vaccine
is delivered in two shots of a 25-microgram dose.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
The committee’s support today
is imperative to providing a critical tool
for pediatricians, parents, and caregivers
who eagerly await an option
for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo.
Both companies are now awaiting approval from
the FDA and the CDC which will hold an advisory
committee meeting on the topic over the weekend.
Category
🗞
News